HLS Therapeutics granted medical device license for One WBC System by Health Canada

HLS Therapeutics Inc (OTCPINK: HLTRF), a specialty pharmaceutical Company developing solutions for the treatment of central nervous system and cardiovascular disorders, announced the grant of a medical device license for the Athela One WBS system. Indicated to serve as a point-of-care device, it is capable...

22 October, 2019 0 Comments

Is Autologous Stem Cell Therapy the next frontier of medicine?

Stem Cell Therapy is emerging as the future of therapeutics for numerous diseases and disorders which have hitherto been unaddressed. The growing awareness of the regenerative powers of stem cells, along with rising research and development expenditure on stem cell technology will drive the growth...

11 April, 2019 0 Comments

WordPress Video Lightbox Plugin

Popular Stories

- Arcutis Biotherapeutics (N

- Nexgel: Bringing Innovatio

- Ekso Bionics: Advancing Ra

- Esperion: Revolutionizing

- AMSC: Restructuring the Po

- Harrow Inc: Envisioning a

SAMPLE REPORTS

Cardiovascular disorders Tag

HLS Therapeutics granted medical device license for One WBC System by Health Canada

Quick Links

Our Service Location

Submit a Request